Diapositive 1

Report
EUROpean network of
transnational collaborative RTD projects
in the field of NANOMEDicine
1
www.euronanomed.net
What are the societal needs?
- the challenge for Europe
Improve public health and welfare
– Ageing population
– Efficiency of current medical
solutions
– Emergence of new disease and old
diseases are back
– Personalized medicine future
directions
www.euronanomed.net
2
The global challenge
• Therapeutic solutions for only
1/3 known diseases (WHO)
• Infections: HIV, TB, malaria,
risk of pandemia
• Need to increase capability
and innovation of medical
industry
– Rapid and accurate diagnosis for
early detection, even prevention
– Novel, more efficient therapies with
less side effects
www.euronanomed.net
3
Nano from research
to patient and industry
Nanomedicine: the application of nanotechnology
to achieve breakthroughs in healthcare
Foto: kaibara87/www.flickr.com
www.euronanomed.net
4
Principle of the
ERA-net scheme
ES
G
UK
F
CP
DE
CP
CP
With ERA-Net
CP
CP
Without ERA-Net
Prog
Prog
F
G
Prog Prog
UK
ES
Prog
DE
…
(CP: Call for projects)
Common transnational dedicated CP
€ : EC supports the coordination costs. Each national programme
supports their national partners within the selected projects
www.euronanomed.net
5
Who we are
24 partners (agencies and ministries)
from 18 countries/regions
Aligning parts of their national /
regional funding programs according
to the FP7 ERA-Net scheme
Started January 2009 for 3 years
EU funding for coordination (FP7)
3 common joint calls for proposals
2009, 2010, 2011
Joint trans-national RTD projects
in nanomedicine
EuroNanoMed achieves a critical mass of actors
www.euronanomed.net
6
EuroNanoMed: an asset to
bridge the gap
Aims of the Calls
Develop innovative diagnostic and therapeutic solutions
for the patient
Solving unmet medical needs
Enhancing the competitiveness of the European health
industry
Maturation of the Nanomedicine field in Europe
Cross-border collaboration between the best researchers /
teams in Nanomedicine, bringing together teams from
 academic / public research
 clinical / public health
 industry
www.euronanomed.net
7
Why now?
What’s the urgency?
• Health industry: a key for future
growth
• European countries invest
substantially in nano industry
and basic nano research
• Nano technologies: a promising
field for innovation and patient
application
Despite these efforts, Europe is lagging behind the US
in an increasing competition :
Europe needs to act now!
www.euronanomed.net
8
Expected outcome
• To move innovation from knowledge to
industrial technology and health care
applications
• Opening the national programmes to support
transnational RTD partnerships
Long term vision:
formula for an Europeanwide integrated programme
with a coordinated funding
www.euronanomed.net
9
Contacts
• Coordinator and Executive Board Chair
Dr. Virginie Sivan
Commissariat à l’Energie Atomique (CEA)
[email protected]
 (+33) 1 69 08 87 99
• Network Steering Committee chair
Dr. Olaf Rotthaus
VDI Technologiezentrum GmbH (VDI)
[email protected]
 (+49) 211 6214-233
www.euronanomed.net
10
Joint Transnational Calls
for proposals : RESULTS
JTC-1: 2009
JTC-2: 2010
www.euronanomed.net
11
RESULTS JTC-1 and JTC-2
Submitted projects
JTC-1 2009
24
JTC-2 2010
33
Partners
117
178
Country/region
19
19
Funded projects
8
8
Partners
40
46
Country/region
14
10
Success rate
33%
24%
Total costs (M€)
16.9
15.9
Requested budget (M€)
9.4
9
www.euronanomed.net
12
Fr
an
Ge ce
rm
an
Sw y
ed
en
S
Sw pai
n
it z
Th
e
e
r la
Ne
nd
th
er
lan
ds
Isr
Ita
ae
ly
l
P
(V
or
en
tu
et
ga
o
l
Re
gi
o
Ro n)
ma
nia
Ita
ly
(N
PC
)
Po
Ba
lan
sq
d
ue
Lit
hu
Re
an
gi
ia
on
(S
pa
in)
Tu
rk
ey
UK
W
De
a ll
(
oo
nm NP
C)
n
ar
Re
k(
g io
NP
n
C)
(B
elg
ium
)
La
tv
Hu ia
ng
Ire
ar
lan
y
d
Be
(N
lgi
PC
um
)
(N
PC
)
Submitted projects
Partners distribution /country-region
JTC-1
www.euronanomed.net
JTC-2
40
35
30
25
20
15
10
5
0
13
Submitted projects
Category of partners
JTC-1 2009
JTC-2 2010
Consortium composition
Translational
Academia
/ public
Academia
research
collaboration
12%
18%
12%
Industry
Industry
25%
Clinic / public
Clinical / public
health
57%
22%
66%
health
66%
Translational
collaboration
22%
48%
52%
Translational Collaboration
Three categories
48%
52%
Three categories
39%
Two categories
(required)
www.euronanomed.net
61%
14
Three categories
1%
Submitted projects
Main scientific subfields
JTC-1 2009
JTC-2 2010
4; 17%
4; 17%
5; 21%
15; 62%
15; 62%
Targeted delivery system
Targeted delivery system
Regenerative medicine
Regenerative medicine
Diagnostic
Diagnostic
9; 27%
17; 52%
7; 21%
www.euronanomed.net
15
Funded projects
Partners /country-region
JTC-1 2009
France
Spain
Germany
Sweden
Switzerland
The Netherlands
Denmark (NPC)
Island
Italy (NPC)
Veneto Region
Lithuania
Poland
Portugal
Basque Region
JTC-2 2010
8
8
7
4
3
2
1
1
1
1
1
1
1
1
France
10
Germany
9
Sweden
6
Portugal
5
Switzerland
5
Spain
5
Romania
3
Poland
1
Turkey
1
Latvia
1
Total 46
Total 40
www.euronanomed.net
16
1%
Funded projects
Main scientific subfields
JTC-1 2009
4; 17%
3
515; 62%
JTC-2 2010
Targeted
delivery
system Targeted delivery system
Regenerative medicine
Regenerative
Diagnostic
medicine
Targeted
delivery
system
Regenera
medicine
2
1
5
Diagnost
-gene therapy
-Immunotherapy
-photodynamic therapy
-anti-cancer therapies
-development of vaccines
-regeneration of the nervous system
and sensory organs.
www.euronanomed.net
-cancer
-inflammatory diseases
-bone regeneration
-muscular dystrophy
-immunology
-vaccines
17
EuroNanoMed: open Call
3rd Joint Transnational
Call for Proposals
14 Countries / Regions
Deadline: April 15th 2011
www.euronanomed.net
18
Participating Funding Organisations
Industry, Innovation, Trade and Tourism Department, Basque
Government
The French National Research Agency (ANR)
VDI Technologiezentrum GmbH
The Icelandic Centre for Research (RANNIS)
The Chief Scientist Office, The Ministry of Health (CSO-MOH)
The Latvian Academy of Sciences (LAS)
Science Council of Lithuania (LSC)
National Centre for Research and Development (NCBiR)
Unitatea Executiva pentru Finantarea Invatamantului Superior, a
Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)
Instituto de Salud Carlos III (ISCIII)
Swiss National Science Foundation (SNSF)
The Scientific and Technological Research Council of Turkey
(TUBITAK)
Project Unit research and innovation, Veneto Region
Ministry of the Walloon Region: Operational General Directorate
for Economy, Employment,and Research (DGOEER)
www.euronanomed.net
BASQUE REGION (SPAIN)
FRANCE
GERMANY
ICELAND
ISRAEL
LATVIA
LITHUANIA
POLAND
ROMANIA
SPAIN
SWITZERLAND
TURKEY
VENETO REGION (ITALY)
WALLOON REGION
(BELGIUM)
19
Topics / Funding
Topics
Diagnostics Targeted
drug delivery
Regenerative medicine
Funding
Indicative total funding 11 M €
Duration: Up to 3 years
Every project partner will receive
the funding from his national
agency
www.euronanomed.net
20
Eligibility criteria
Consortium composition
3 – 7 partners per consortium
Partners from at least 3 different countries
(with a majority of partners from funding member states/regions participating
in the call)
Partners from at least two of the three categories
 academic / public research
 clinical / public health
 industry
Eligibility of partners also depends on national regulation in
their country or region!
Read carefully the “Country specific information for applicants”
Contact your national agency (contact person)
www.euronanomed.net
21
Time lines
Call open since:
January 14th 2011
Deadline for proposals: April 15th 2010,
17:00:00 (Brussels Time)
Funding Decision:
October 2011
Start of Projects:
January 2012
www.euronanomed.net
22
How to apply?
1. EuroNanoMed Website
www.euronanomed.net
www.euronanomed.net
23
How to apply?
2. Download Call Text , Guidelines for
applicants and Country specific Information
www.euronanomed.net
24
How to apply?
3. Contact your national contact point
(list in the Country-region specific information)
4. Download and fill in the Proposal Template
www.euronanomed.net
25
How to apply?
5. Online Submission using the
EuroNanoMed Submission Tool
www.nanomedsubmission.net
www.euronanomed.net
26
How to apply?
Register by clicking on the link ”to register” on the homepage
http://www.euronanomed.net/*; you will receive an email
confirming your registration
Accede to the EuroNanoMed Electronic Submission System*
(Use the username and password you chose for the registration)
fill in all the details and upload your proposal document (pdf
format only), which you have previously filled in on your computer
(see The Proposal Template)*.
Submit your proposal : Click on “submit proposal” to confirm
your submission; you will receive an email confirming its receipt.
Modify your data at any time until the submission deadline.
It is strongly recommended to transfer the final version
in proper time before this date
www.euronanomed.net
27
Expression of Interest Tool
Present your project ideas
Find partners
www.nanomedsubmission.net
www.euronanomed.net
28
For more information
EuroNanoMed Call Office
Veneto Nanotech s.c.p.a.
Via San Crispino, 106
35129 Padova – Italy
 : +39 049 7705520
e-mail: [email protected]
National / Regional Contact Points
www.euronanomed.net
www.euronanomed.net
29
Together we are building
Nanomedicine for the future!
30
www.euronanomed.net

similar documents